title: Novel targets and regulatory ordeal by QT interval.
authors.forename: J M
authors.initials: JM
authors.lastname: Ritter
mesh_terms: D000818:Animals; D004562:Electrocardiography / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D051381:Rats; D013927:Thrombosis / Q000188:drug therapy
chemical_list: D010972:Platelet Activating Factor
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):396-404
references.pmid: 18662287
references.citation: Br J Clin Pharmacol. 2010 Apr;69(4):401-10
references.pmid: 20406224
references.citation: Br J Pharmacol. 2010 Jan;159(1):34-48
references.pmid: 19775279
references.citation: Br J Clin Pharmacol. 2008 Feb;65(2):154-7
references.pmid: 18251756
references.citation: Arch Mal Coeur Vaiss. 1966 Feb;59(2):263-72
references.pmid: 4956181
references.citation: Br J Clin Pharmacol. 2009 Sep;68(3):318-9
references.pmid: 19740388
references.citation: Br J Clin Pharmacol. 2010 May;69(5):425-6
references.pmid: 20573077
references.citation: J Pharmacol Exp Ther. 1997 Jan;280(1):114-21
references.pmid: 8996188
references.citation: Br J Pharmacol. 2010 Jan;159(1):5-11
references.pmid: 20141515
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):341-4
references.pmid: 18782140
references.citation: Br J Pharmacol. 2010 Jan;159(1):70-6
references.pmid: 20141519
references.citation: Drugs. 2007;67(3):457-74
references.pmid: 17335300
references.citation: Br J Clin Pharmacol. 2010 Apr;69(4):391-400
references.pmid: 20406223
references.citation: Nat Rev Immunol. 2009 Jan;9(1):62-70
references.pmid: 19104500
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):375-85
references.pmid: 18662288
references.citation: Biochem Pharmacol. 2005 May 1;69(9):1325-31
references.pmid: 15826603
references.citation: Br J Pharmacol. 2010 Jan;159(1):58-69
references.pmid: 19563537